TrialAddiction biology2023

Delta-9-tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study.

Joao P De Aquino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.